Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_06802 | 19 | 0.40 | Mlig455_033458 | Neo: - Age: - |
Mlig455_033458 {REF} {Length: 861} {RNA1310_100612} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.621 | 0.864 | 0.99955 | 1.00000 | |
RegionR2 | 0.131 | 0.864 | 0.59671 | 0.94825 | |
RegionR3 | -2.303 | 0.864 | 0.99965 | 1.00000 | |
RegionR4 | 0.922 | 0.864 | 0.36123 | 0.68419 | |
RegionR5 | -2.214 | 0.864 | 0.99962 | 1.00000 | |
RegionR6 | -0.226 | 0.864 | 0.60743 | 1.00000 | |
RegionR7 | 2.883 | 0.864 | 0.08473 | 0.56055 | |
RegionR8 | -0.814 | 0.864 | 0.99966 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -3.717 | 0.864 | 0.99991 | 1.00000 | |
RegenerationR2 | -0.327 | 0.864 | 0.70072 | 0.95679 | |
RegenerationR3 | 2.121 | 0.864 | 0.24515 | 0.67918 | |
RegenerationR4 | -0.647 | 0.864 | 0.71619 | 0.95987 | |
RegenerationR5 | 1.501 | 0.864 | 0.21839 | 0.65300 | |
RegenerationR6 | -0.377 | 0.864 | 0.73281 | 0.94243 | |
RegenerationBL | -3.984 | 0.864 | 0.99967 | 1.00000 | |
RegenerationTP | 0.657 | 0.864 | 0.75057 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_06802 | 19 | 0.4 | Mlig455_033458 | Neo: - Age: - |
2 | - | - | - | - | 1.000 | 1.000 | Mlig455_033458 {REF} {Length: 861} {RNA1310_100612} | |
2. | MligTC455_42902 | 28 | 0.59 | Mlig455_017220 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_017220 {REF} {Length: 656} {NoTransDecoderORF} {RNA1509_43125} {RNA1310_24647} {RNA815_24974} | |
3. | MligTC455_21793 | 16 | 0.33 | Mlig455_062163 | Neo: - Age: - |
0.964 | - | - | - | - | - | 0.964 | Mlig455_062163 {REF} {Length: 647} {NoTransDecoderORF} {RNA1509_41508} {RNA1310_104721} {RNA815_45877.1} | |
4. | MligTC455_45076 | 339 | 7.05 | Mlig455_039678 | Neo: - Age: logFC(26M/2M)=-0.542 |
0.963 | - | - | - | - | - | 0.963 | Mlig455_039678 {REF} {Length: 2714} {RNA1310_20698} {RNA815_32653} | |
5. | MligTC455_07394 | 59 | 1.22 | Mlig455_057223 | Neo: Int S/G2/M Age: - |
0.961 | - | - | - | - | - | 0.961 | Mlig455_057223 {REF} {Length: 738} {NoTransDecoderORF} {RNA1310_52033} | |
6. | MligTC455_05870 | 60 | 1.25 | Mlig455_062138 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_062138 {REF} {Length: 1049} {NoTransDecoderORF} {RNA1310_117144} | |
7. | MligTC455_21780 | 19 | 0.4 | Mlig455_027652 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_027652 {REF} {Length: 1944} {Pfam: WSC domain [PF01822.21, score=50.5]; PAN domain [PF00024.28, score=19.1]} {RNA1509_53783} {RNA1310_34968.1} {RNA815_24434} | |
8. | MligTC455_36784 | 15 | 0.3 | Mlig455_046783, Mlig455_069957 | Neo: - Age: logFC(26M/2M)=-0.515 |
0.957 | - | - | - | - | 0.957 | - | Mlig455_046783 {REF} {Length: 1605} {RNA1509_14365} {RNA1310_13117.2} {RNA815_6458.1} Mlig455_069957 {REF} {Length: 1377} {RNA1509_14365} {RNA1310_13117.4} {RNA815_6458.1} |
|
9. | MligTC455_47805 | 309 | 6.43 | Mlig455_002866, Mlig455_033201 | Neo: - |
NR2C2 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_002866 {REF} {Length: 2397} {RNA1509_25172} {RNA1310_17963.1} {RNA815_11681} Mlig455_033201 {REF} {Length: 2405} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=86.4]} {Human: ENSG00000177463, NR2C2, nuclear receptor subfamily 2 group C member 2, [Score=90.5, Expect=1e-18]; ENSG00000120798, NR2C1, nuclear receptor subfamily 2 group C member 1, [Score=87.8, Expect=4e-18]; ENSG00000101076, HNF4A, hepatocyte nuclear factor 4 alpha, [Score=87.4, Expect=7e-18]; ENSG00000113580, NR3C1, nuclear receptor subfamily 3 group C member 1, [Score=87.4, Expect=2e-17]; ENSG00000175745, NR2F1, nuclear receptor subfamily 2 group F member 1, [Score=87.0, Expect=6e-18]; ENSG00000160113, NR2F6, nuclear receptor subfamily 2 group F member 6, [Score=86.7, Expect=9e-18]; ENSG00000151623, NR3C2, nuclear receptor subfamily 3 group C member 2, [Score=86.7, Expect=3e-17]} {Mouse: ENSMUSG00000005893, Nr2c2, nuclear receptor subfamily 2, group C, member 2, [Score=88.2, Expect=5e-18]; ENSMUSG00000017950, Hnf4a, hepatic nuclear factor 4, alpha, [Score=88.2, Expect=3e-18]; ENSMUSG00000069171, Nr2f1, nuclear receptor subfamily 2, group F, member 1, [Score=87.0, Expect=5e-18]; ENSMUSG00000031618, Nr3c2, nuclear receptor subfamily 3, group C, member 2, [Score=87.0, Expect=1e-17]; ENSMUSG00000005897, Nr2c1, nuclear receptor subfamily 2, group C, member 1, [Score=86.7, Expect=1e-17]; ENSMUSG00000002393, Nr2f6, nuclear receptor subfamily 2, group F, member 6, [Score=85.9, Expect=9e-18]; ENSMUSG00000030551, Nr2f2, nuclear receptor subfamily 2, group F, member 2, [Score=85.1, Expect=2e-17]; ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=85.1, Expect=4e-17]; ENSMUSG00000024431, Nr3c1, nuclear receptor subfamily 3, group C, member 1, [Score=85.1, Expect=5e-17]; ENSMUSG00000026398, Nr5a2, nuclear receptor subfamily 5, group A, member 2, [Score=84.3, Expect=7e-17]} {Dmel: FBgn0264562, Hr4, Hormone receptor 4, [Score=96.3, Expect=1e-20]} {Celegans: WBGene00003681, nhr-91, Nuclear hormone receptor family member nhr-91, [Score=89.7, Expect=5e-19]} {Smed: dd_Smed_v6_33286_0_2, dd_Smed_v6_33286_0_2, [Score=86.7, Expect=6e-19]} {RNA1509_25172} {RNA1310_17963.1, RNA1509_25172} {RNA1509_25172, RNA815_11681} |
10. | MligTC455_11133 | 24 | 0.5 | Mlig455_036188 | Neo: Int S/G2/M Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_036188 {REF} {Length: 1185} {NoTransDecoderORF} {RNA1509_60021} {RNA1310_108053} {RNA815_10011.1} | |
11. | MligTC455_28594 | 49 | 1.02 | Mlig455_013080 | Neo: - Age: Up-Up-Down |
0.952 | - | - | - | - | 0.952 | - | Mlig455_013080 {REF} {Length: 2167} {NoTransDecoderORF} {RNA1509_57922} {RNA1310_17062} {RNA815_22796.1} | |
12. | MligTC455_30695 | 18 | 0.38 | Mlig455_054232 | Neo: - Age: - |
0.952 | - | - | - | - | 0.952 | - | Mlig455_054232 {REF} {Length: 3944} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=123.4]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=118.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=71.9]} {Smed: dd_Smed_v6_1574_6_43, dd_Smed_v6_1574_6_43, [Score=258, Expect=9e-82]} {RNA1509_30575} {RNA1310_870} {RNA815_993.1} | |
13. | MligTC455_23607 | 144 | 3 | Mlig455_045837 | Neo: - Age: - |
ANK2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_045837 {REF} {Length: 7013} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=594.9]; Ankyrin repeats (many copies) [PF13637.8, score=559.1]; Ankyrin repeats (many copies) [PF13857.8, score=368.7]; Ankyrin repeat [PF13606.8, score=367.3]; Ankyrin repeat [PF00023.32, score=277.3]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=235, Expect=3e-62]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=239, Expect=1e-63]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=212, Expect=8e-55]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=199, Expect=1e-51]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=245, Expect=8e-67]} {RNA1509_19596, RNA1509_41973} {RNA1310_2241.1, RNA1509_19596, RNA1509_41973} {RNA1509_19596, RNA1509_41973, RNA815_5124} |
14. | MligTC455_51584 | 89 | 1.86 | Mlig455_013928 | Neo: - Age: - |
PICK1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_013928 {REF} {Length: 2404} {Pfam: Arfaptin-like domain [PF06456.15, score=243.5]; PDZ domain [PF00595.26, score=41.9]; PDZ domain [PF17820.3, score=37.4]; PDZ domain [PF13180.8, score=30.4]; BAR domain [PF03114.20, score=29.7]; BAR domain of APPL family [PF16746.7, score=20.7]} {Human: ENSG00000100151, PICK1, protein interacting with PRKCA 1, [RH, Score=507, Expect=1e-178]} {Mouse: ENSMUSG00000068206, Pick1, protein interacting with C kinase 1, [RH, Score=506, Expect=3e-178]} {Dmel: FBgn0032447, PICK1, Protein interacting with C kinase 1, [RH, Score=462, Expect=4e-160]} {Celegans: WBGene00013317, Y57G11C.22, [RH, Score=346, Expect=2e-115]} {Smed: dd_Smed_v6_2968_0_2, dd_Smed_v6_2968_0_2, [RH, Score=579, Expect=0.0]} {RNA1509_32506} {RNA1310_11997.1} {RNA815_9939} |
15. | MligTC455_06332 | 14 | 0.28 | Mlig455_057922 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_057922 {REF} {Length: 345} {NoTransDecoderORF} {RNA1310_58645} {RNA815_60376} | |
16. | MligTC455_24612 | 12 | 0.25 | Mlig455_000425, Mlig455_000489, Mlig455_000526, Mlig455_024858 | Neo: - Age: - |
SCN1A | 0.95 | - | - | - | - | 0.950 | - | Mlig455_000425 {REF} {Length: 2186} {Pfam: Ion transport protein [PF00520.33, score=296.1]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.9]; Polycystin cation channel [PF08016.14, score=23.2]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=502, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=498, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=490, Expect=7e-153]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=486, Expect=2e-151]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=486, Expect=9e-152]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=481, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=481, Expect=4e-150]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=500, Expect=7e-157]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=494, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=490, Expect=4e-153]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=484, Expect=2e-151]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=484, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=483, Expect=1e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=481, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=475, Expect=6e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=538, Expect=2e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=189, Expect=6e-50]} {Smed: dd_Smed_v6_13973_0_1, dd_Smed_v6_13973_0_1, [Score=610, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000489 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=23.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=504, Expect=4e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=9e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=1e-151]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=483, Expect=9e-150]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=482, Expect=8e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=479, Expect=4e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=2e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=1e-150]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=483, Expect=6e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=5e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=627, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_000526 {REF} {Length: 2384} {Pfam: Ion transport protein [PF00520.33, score=296.7]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=31.7]; Polycystin cation channel [PF08016.14, score=22.9]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=503, Expect=3e-157]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=501, Expect=2e-156]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=492, Expect=8e-153]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=489, Expect=8e-152]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=488, Expect=2e-151]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=484, Expect=1e-149]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=483, Expect=6e-150]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=478, Expect=5e-148]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=502, Expect=1e-156]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=496, Expect=3e-155]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=493, Expect=3e-153]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=487, Expect=4e-151]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=486, Expect=4e-151]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=486, Expect=2e-150]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=484, Expect=5e-150]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=478, Expect=7e-148]} {Dmel: FBgn0285944, para, paralytic, [Score=541, Expect=1e-170]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=191, Expect=6e-50]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=628, Expect=0.0]} {RNA1509_56147} {RNA1310_51142} Mlig455_024858 {REF} {Length: 1954} {Pfam: Ion transport protein [PF00520.33, score=318.3]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=32.1]; Polycystin cation channel [PF08016.14, score=30.0]} {Human: ENSG00000144285, SCN1A, sodium voltage-gated channel alpha subunit 1, [Score=660, Expect=0.0]; ENSG00000136531, SCN2A, sodium voltage-gated channel alpha subunit 2, [Score=654, Expect=0.0]; ENSG00000169432, SCN9A, sodium voltage-gated channel alpha subunit 9, [Score=649, Expect=0.0]; ENSG00000183873, SCN5A, sodium voltage-gated channel alpha subunit 5, [Score=640, Expect=0.0]; ENSG00000153253, SCN3A, sodium voltage-gated channel alpha subunit 3, [Score=639, Expect=0.0]; ENSG00000007314, SCN4A, sodium voltage-gated channel alpha subunit 4, [Score=635, Expect=0.0]; ENSG00000196876, SCN8A, sodium voltage-gated channel alpha subunit 8, [Score=631, Expect=0.0]; ENSG00000185313, SCN10A, sodium voltage-gated channel alpha subunit 10, [Score=627, Expect=0.0]} {Mouse: ENSMUSG00000064329, Scn1a, sodium channel, voltage-gated, type I, alpha, [Score=655, Expect=0.0]; ENSMUSG00000001027, Scn4a, sodium channel, voltage-gated, type IV, alpha, [Score=652, Expect=0.0]; ENSMUSG00000075318, Scn2a, sodium channel, voltage-gated, type II, alpha, [Score=646, Expect=0.0]; ENSMUSG00000075316, Scn9a, sodium channel, voltage-gated, type IX, alpha, [Score=645, Expect=0.0]; ENSMUSG00000057182, Scn3a, sodium channel, voltage-gated, type III, alpha, [Score=637, Expect=0.0]; ENSMUSG00000032511, Scn5a, sodium channel, voltage-gated, type V, alpha, [Score=635, Expect=0.0]; ENSMUSG00000023033, Scn8a, sodium channel, voltage-gated, type VIII, alpha, [Score=630, Expect=0.0]; ENSMUSG00000034533, Scn10a, sodium channel, voltage-gated, type X, alpha, [Score=623, Expect=0.0]} {Dmel: FBgn0285944, para, paralytic, [Score=701, Expect=0.0]} {Celegans: WBGene00001187, egl-19, Voltage-dependent L-type calcium channel subunit alpha, [Score=268, Expect=3e-77]} {Smed: dd_Smed_v6_14386_0_1, dd_Smed_v6_14386_0_1, [Score=816, Expect=0.0]} {RNA1310_51142} |
17. | MligTC455_50119 | 18 | 0.37 | Mlig455_059375 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_059375 {REF} {Length: 132} {NoTransDecoderORF} {RNA1509_25973} {RNA1310_63860} {RNA815_5524} |